Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

120.17
Delayed Data
As of Mar 02
 +0.74 / +0.62%
Today’s Change
59.79
Today|||52-Week Range
127.69
+1.15%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line29.6M-162.9M-687.6M-742.7M
 
 
 
 
 
Depreciation35.0M38.2M48.4M63.3M
 
 
 
 
 
Total Other Cash Flow279.7M369.7M877.7M177.1M
 
 
 
 
 
Funds From Operations336.8M281.6M-46.5M-502.1M
 
 
 
 
 
Funds From/For Other Operating Expenses193.1M13.8M5.1M11.1M
 
 
 
 
 
Net Cash Flow - Operating Activities143.7M267.8M-51.6M-513.2M
 
 
 
 
 
 
InvestingIncrease In Investments-721.5M-1.7B-2.4B-1.4B
 
 
 
 
 
Decrease In Investments1.0B1.4B2.3B1.6B
 
 
 
 
 
Capital Expenditures-34.6M-71.1M-51.4M-51.2M
 
 
 
 
 
Net Assets From Acquisitions -60.0M0.000.000.00
 
 
Other Investing - Uses-183.0K-18.9M0.00-10.2M
 
 
 
 
Other Investing - Sources12.7M2.2M61.4M1.6M
 
 
 
 
 
Net Cash Flow Investing212.4M-425.8M-54.1M74.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.00302.3M
 
 
Long Term Debt Reduction-155.0M-21.5M-83.7M-81.7M
 
 
 
 
 
Net Proceeds Stock Sale124.9M191.7M265.9M274.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing900.0K2.0M0.002.2M
 
 
 
 
Other Uses - Financing95.0M0.001.3M0.00
 
 
 
Net Cash Flow - Financing-124.2M172.2M180.9M497.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash214.0K-141.0K4.7M-2.2M
 
 
 
 
 
 
Net Change In Cash231.9M14.2M75.2M58.1M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account